Leqembi Injection, Solution
Product Images NDC 62856-212

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Leqembi (NDC 62856-212). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eisai Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Reduction In Brain Amyloid Beta Plaque (adjusted Mean Change From Baseline In Amyloid Beta Pet Composite, Suvr And Centiloids) In Study 1 (Lecanemab 01)

Figure 1: Reduction In Brain Amyloid Beta Plaque (adjusted Mean Change From Baseline In Amyloid Beta Pet Composite, Suvr And Centiloids) In Study 1 (Lecanemab 01)
FDA Label Image

Principal Display Panelleqembindc 62856-215-01(lecanemab-irmb)injection500 mg/5 mL(100 mg/ml)single-dose Vial (Lecanemab 02)

Principal Display Panelleqembindc 62856-215-01(lecanemab-irmb)injection500 mg/5 mL(100 mg/ml)single-dose Vial (Lecanemab 02)
LEQEMBI" is a prescription drug for intravenous infusion only. The injection must be diluted before use, with a dosage prescribed by a doctor. The drug is available in a single-dose vial and manufactured by Eisai Inc. The unused portion should be discarded. No further information is available from the provided text.*
FDA Label Image

Principal Display Panelleqembindc 62856-215-01(lecanemab-irmb)injection500 mg/5 mL(100 mg/ml) (Lecanemab 03)

Principal Display Panelleqembindc 62856-215-01(lecanemab-irmb)injection500 mg/5 mL(100 mg/ml) (Lecanemab 03)
FDA Label Image

Principal Display Panelleqembindc 62856-212-01(lecanemab-irmb)injection200 mg/2 mL(100 mg/ml)single-dose Vial (Lecanemab 04)

Principal Display Panelleqembindc 62856-212-01(lecanemab-irmb)injection200 mg/2 mL(100 mg/ml)single-dose Vial (Lecanemab 04)
This is a description of a medication named "LEQEMBI" (lecanemab-irmb). It is an injection drug that comes in a 200 mg/2 mL single-dose vial. Unused portions must be discarded. The NDC code is 62856-212-01, and the medication is for intravenous infusion only after prior dilution. The prescribing information should be consulted for the proper dosage. It is manufactured by Eisai Inc., with US License No. 1862.*
FDA Label Image

Principal Display Panelleqembindc 62856-212-01(lecanemab-irmb)injection200 mg/2 mL(100 mg/ml) (Lecanemab 05)

Principal Display Panelleqembindc 62856-212-01(lecanemab-irmb)injection200 mg/2 mL(100 mg/ml) (Lecanemab 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.